Black Diamond Therapeutics Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -285.2% | – | – | – | -2,917.6% | 76.3% | – | – | – | – | – | – | |
| – | 1.8% | – | – | – | 16.5% | 0.1% | – | – | – | – | – | – | |
| – | 31.4% | – | – | – | 317.1% | 2.4% | – | – | – | – | – | – | |
| – | 80.2% | – | – | – | -158.1% | -7.5% | – | – | – | – | – | – | |
| – | 0.7% | – | – | – | 0.0% | 0.0% | – | – | – | – | – | – | |
| – | 250.3% | – | – | – | 5,381.6% | 12.2% | – | – | – | – | – | – | |
| – | 0.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.9% | – | – | – | 56.4% | 0.0% | – | – | – | – | – | – | |
| – | -35.8% | – | – | – | 2,520.3% | 88.6% | – | – | – | – | – | – | |
| – | -285.2% | – | – | – | -2,917.6% | 76.3% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.